En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Waste Management

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood & Blood Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Point-Of-Care Testing

Browse Products by Category

Close

Biocartis SA

Biocartis SA

Biocartis is a commercial stage molecular diagnostics company that develops diagnostics technology platforms for multiplexed detection of bio-analytes. Its diagnostic solutions are aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry, and its platforms can be used in a wid ...
Products Covid-19Summary
Close

Covid-19 Biocartis SA

Clinical Laboratory

SARS-CoV-2 Test
Idylla SARS-CoV-2 Test

The Idylla SARS-CoV-2 Test is an automated rRT-PCR test intended for the qualitative detection of SARS-CoV-2 RNA in nasopharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Results are obtained using 200 μl of viral transport media (VTM) in as soon as 90 minutes with less than two minutes hands-on time. The test is performed on the Idylla platform capable of fully automated nucleic acid testing including extraction, amplification, and detection in a single-use cartridge.
More details
Close

About Biocartis SA

Biocartis is a commercial stage molecular diagnostics company that develops diagnostics technology platforms for multiplexed detection of bio-analytes. Its diagnostic solutions are aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry, and its platforms can be used in a wide variety of healthcare settings.

Recently updated

Sepsis Detection Test
SeptiCyte RAPID

The fully automated SeptiCyte RAPID is a rapid host-response test that distinguishes sepsis from non-infectious systemic inflammation (INSI/SIRS). The test provides actionable results in about one hour enabling physicians to optimize their patient management decisions. The test is performed on the Idylla platform capable of fully automated nucleic acid testing including extraction, amplification, and detection in a single-use cartridge.
More details

SARS-CoV-2 Test
Idylla SARS-CoV-2 Test

The Idylla SARS-CoV-2 Test is an automated rRT-PCR test intended for the qualitative detection of SARS-CoV-2 RNA in nasopharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Results are obtained using 200 μl of viral transport media (VTM) in as soon as 90 minutes with less than two minutes hands-on time. The test is performed on the Idylla platform capable of fully automated nucleic acid testing including extraction, amplification, and detection in a single-use cartridge.
More details

Mutation Assay Kit
Idylla EGFR Mutation Assay (RUO)

The Idylla EGFR Mutation Assay (RUO) allows detection of EGFR mutations directly from formalin-fixed paraffin-embedded tissue sections in approx. 2.5 hours with less than 2 minutes hands-on time. Performed on the Biocartis Idylla system, the assay is available for the qualitative detection of 53 mutations in exons 18, 19, 20 and 21 of the EGFR gene.
More details

Clinical Laboratory

Sepsis Detection Test
SeptiCyte RAPID

The fully automated SeptiCyte RAPID is a rapid host-response test that distinguishes sepsis from non-infectious systemic inflammation (INSI/SIRS). The test provides actionable results in about one hour enabling physicians to optimize their patient management decisions. The test is performed on the Idylla platform capable of fully automated nucleic acid testing including extraction, amplification, and detection in a single-use cartridge.
More details

SARS-CoV-2 Test
Idylla SARS-CoV-2 Test

The Idylla SARS-CoV-2 Test is an automated rRT-PCR test intended for the qualitative detection of SARS-CoV-2 RNA in nasopharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Results are obtained using 200 μl of viral transport media (VTM) in as soon as 90 minutes with less than two minutes hands-on time. The test is performed on the Idylla platform capable of fully automated nucleic acid testing including extraction, amplification, and detection in a single-use cartridge.
More details

Mutation Assay Kit
Idylla EGFR Mutation Assay (RUO)

The Idylla EGFR Mutation Assay (RUO) allows detection of EGFR mutations directly from formalin-fixed paraffin-embedded tissue sections in approx. 2.5 hours with less than 2 minutes hands-on time. Performed on the Biocartis Idylla system, the assay is available for the qualitative detection of 53 mutations in exons 18, 19, 20 and 21 of the EGFR gene.
More details

Influenza Molecular Assay
Idylla Respiratory IFV-RSV Panel

The Idylla Respiratory IFV-RSV Panel is a molecular assay that identifies viruses with high sensitivity in as quickly as 50 minutes, and requires less than one minute of hands-on time. The highly sensitive and highly specific panel identifies the presence of influenza or RSV and allows samples to be obtained directly from nasopharyngeal swab in viral transport media.
More details

Molecular Diagnostics System
Idylla

The Idylla is a fully automated, real-time PCR based molecular diagnostics system that covers the entire process from sample to result in a time frame of 35 to 150 minutes with less than two minutes of hands-on time. The fully integrated system can analyze both RNA and DNA and enables clinical laboratories to perform a broad range of applications in oncology, infectious diseases and beyond.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions